Cyclopentolate ophthalmic and Lorcaserin Extended-Release Tablets
Determining the interaction of Cyclopentolate ophthalmic and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclopentolate ophthalmic
Brand name: Cyclogyl, Cylate, AK-Pentolate, Pentolair, Ocu-Pentolate
Synonyms: Cyclopentolate Hydrochloride
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclopentolate ophthalmic-Lorcaserin Hydrochloride
- Cyclopentolate ophthalmic-Lorcaserin Tablets
- Cyclopentolate ophthalmic-Lorcet
- Cyclopentolate ophthalmic-Lorcet Plus
- Cyclopentolate ophthalmic-Lorcet Tablets
- Cyclopentolate ophthalmic-Lorlatinib
- Lorcaserin Extended-Release Tablets-Cyclophosphamide
- Lorcaserin Extended-Release Tablets-Cyclophosphamide Capsules
- Lorcaserin Extended-Release Tablets-Cyclophosphamide Injection
- Lorcaserin Extended-Release Tablets-Cyclophosphamide oral and injection
- Lorcaserin Extended-Release Tablets-Cyclophosphamide Oral, Intravenous
- Lorcaserin Extended-Release Tablets-Cyclophosphamide Tablets